| Oct 17 |
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024
|
| Oct 14 |
Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial
|
| Aug 3 |
Sight Sciences, Inc. (SGHT) Q2 2024 Earnings Call Transcript
|
| Aug 2 |
Q2 2024 Sight Sciences Inc Earnings Call
|
| Aug 1 |
Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 1 |
Sight Sciences GAAP EPS of -$0.25 beats by $0.04, revenue of $21.4M beats by $0.05M
|
| Aug 1 |
Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance
|
| Jul 25 |
Integer (ITGR) Q2 Earnings Surpass Estimates
|
| Jul 18 |
Sight Sciences to Report Second Quarter Financial Results on August 1, 2024
|
| Jul 10 |
CVRx plunges, Sight Sciences jumps on proposed Medicare rate changes
|
